Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.556
Buy
RSI(14)
54.937
Neutral
STOCH(KDJ)(9,3,3)
57.066
Neutral
ATR(14)
6.809
Low Volatility
CCI(14)
38.849
Neutral
Williams %R
39.659
Buy
TRIX(12,20)
0.306
Sell
StochRSI(14)
0.000
Sell
Search
Insulet Corp
PODDAdd to Watchlist
165.350USD
-0.330-0.20%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.45BMarket Cap
38.36P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-0.20%
5 Days
+1.28%
1 Month
+8.60%
6 Months
-35.36%
Year to Date
-41.83%
1 Year
-42.67%
Key Figures
164.570Open
168.360High
1.31MVolume
38.36P/E TTM
20.27P/E Dynamic
--Dividend TTM
1.90%Turnover Ratio
165.680Prev. Close
162.425Low
156.84MTurnover
27.38P/E Static
8.79P/B
0.00%Div Yield TTM
9.31%ROA
354.88052wk High
1.11Volume Ratio
418.30MNet Profit
69.26MShares
4.3105EPS TTM
1.14Beta
23.00%ROE
140.63052wk Low
3.58%Amplitude
69.45%Gross Margin
11.45BMarket Cap
0.34Reward/Risk
2.14%Risk Rate
TradingKey Stock Score of Insulet Corp
Currency: USD Updated: 2026-07-31Key Insights
Insulet Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 14 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 243.88.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Insulet Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
38°C
Very Low
Very High
Positive
Insulet Corp Highlights
StrengthsRisks
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 59.57% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.71B.
Undervalued
The company’s latest PE is 38.36, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 73.18M shares, decreasing 2.16% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.50.
Analyst Rating
Based on
27
analysts
Buy
Current Rating
243.880
Target Price
+42.94%
Upside Space
Insulet Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
27
analysts
Buy
Current Rating
243.880
Target Price
+42.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Insulet Corp
PODD
27
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
166.824
Sell
MA10
164.578
Buy
MA20
162.654
Buy
MA50
155.325
Buy
MA100
174.936
Sell
MA200
232.148
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Insulet Corp Info
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
Ticker SymbolPODD
CompanyInsulet Corp
CEOMcevoy (Ashley)
Websitehttps://www.omnipod.com
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Insulet Corp (PODD)?
The current price of Insulet Corp (PODD) is 165.35.
What is the symbol of Insulet Corp?
The ticker symbol of Insulet Corp is PODD.
What is the 52-week high of Insulet Corp?
The 52-week high of Insulet Corp is 354.88.
What is the 52-week low of Insulet Corp?
The 52-week low of Insulet Corp is 140.63.
What is the market capitalization of Insulet Corp?
The market capitalization of Insulet Corp is 11.45B.
Is Insulet Corp (PODD) currently rated as Buy, Hold, or Sell?
According to analysts, Insulet Corp (PODD) has an overall rating of Buy, with a price target of 243.88.
What is the Earnings Per Share (EPS TTM) of Insulet Corp (PODD)?
The Earnings Per Share (EPS TTM) of Insulet Corp (PODD) is 3.51.